Futura Medical Share Discussion Threads

[ih_344101] 31/7/2023 17:23

‘companies must give you enough accurate information to enable you to make an informed buying decision. Find out more about contract information. If they fail to provide this information, their actions may be considered unfair. You have the right to seek redress if you are treated unfairly‘



‘the MDD did not harmonise EU law relating the advertising of medical devices, which was subject to Directive 2005/29/EC on unfair business to consumer commercial practices (including advertising) generally (Unfair commercial practices directive - UCPD). That meant that advertisers must still meet the requirements of the CAP Code, which reflected the provisions of UCPD. Under the CAP and BCAP Codes, medical claims could be made for CE-marked medical devices provided they complied with other requirements of the Codes, including those relating to substantiation’

˜When promoting, selling or supplying products, companies must give you enough accurate information to enable you to make an informed buying decision. Find out more about contract information. If they fail to provide this information, their actions may be considered unfair. You have the right to seek redress if you are treated unfairly’



Unfair commercial practices

When you buy goods and services anywhere in the EU from a website, a local shop or a seller outside your home countrys EU law protects you against unfair commercial practices. When promoting, selling or supplying products, companies must give you enough accurate information to enable you to make an informed buying decision. Find out more about contract information. If they fail to provide this information, their actions may be considered unfair. You have the right to seek redress if you are treated unfairly.

Misleading and aggressive practices

You are protected against 2 main categories of unfair commercial practices: misleading practices, either through action (giving false information) or omission (leaving out important information) aggressive practices that aim to bully you into buying Certain commercial practices are prohibited in all circumstances. Some of the most common are listed below:

Whenever a product is advertised as therapeutic, curing allergies, reversing hair loss, helping you lose weight, etc. you have the right to know if such claims have been scientifically confirmed.

In many cases, claims like these are not medically backed up and are simply TOO GOOD TO BE TRUE



Medical device claims that breach CAP Code (Edition 12) rules 3.1 (Misleading advertising), 3.7 (Substantiation) and 12.1 Medicines, medical devices

‘Because the trial was not placebo-controlled’

˜had not provided adequate evidence to support the claim ˜clinically proven’, ‘concluded that the claim had not been substantiated and was misleading’



Assessment
Upheld

The ASA noted that the product appeared to meet the requirements of the Medical Device Directive (MDD) but understood that the MDD did not harmonise EU law relating the advertising of medical devices, which was subject to Directive 2005/29/EC on unfair business to consumer commercial practices (including advertising) generally (Unfair commercial practices directive - UCPD).

That meant that advertisers must still meet the requirements of the CAP Code, which reflected the provisions of UCPD. Under the CAP and BCAP Codes, medical claims could be made for CE-marked medical devices provided they complied with other requirements of the Codes, including those relating to substantiation.

CE certification in itself does not constitute evidence for medical efficacy claims, and advertisers need to ensure that they hold evidence for such claims.

There was no statistically significant difference between the outcomes for the treatment group (patients using the Aerosure device) and the control group (using an inactive sham device). The study was accordingly not adequate evidence of the efficacy



Because the trial was not placebo-controlled, we considered AcceleDent had not provided adequate evidence to support the claim AcceleDent, is also clinically proven to reduce the pain and discomfort associated with braces and aligners by up to 71%. We concluded that the claim had not been substantiated and was misleading.

On that point the claim breached CAP Code (Edition 12) rules 3.1 (Misleading advertising), 3.7 (Substantiation) and 12.1 Medicines, medical devices, health-related products and beauty products.



Assessment
Upheld

The ASA noted that the product appeared to meet the requirements of the Medical Device Directive (MDD) but understood that the MDD did not harmonise EU law relating the advertising of medical devices, which was subject to Directive 2005/29/EC on unfair business to consumer commercial practices (including advertising) generally (Unfair commercial practices directive - UCPD).

That meant that advertisers must still meet the requirements of the CAP Code, which reflected the provisions of UCPD. Under the CAP and BCAP Codes, medical claims could be made for CE-marked medical devices provided they complied with other requirements of the Codes, including those relating to substantiation.

CE certification in itself does not constitute evidence for medical efficacy claims, and advertisers need to ensure that they hold evidence for such claims.

There was no statistically significant difference between the outcomes for the treatment group (patients using the Aerosure device) and the control group (using an inactive sham device). The study was accordingly not adequate evidence of the efficacy

[petroc] 31/7/2023 17:09

LBO131 Jul '23 - 16:51 - 19635 of 19635
0 0 0
All it will take is one dissatisfied customer to then take a closer look beyond the ‘clinically proven’ claim on the packaging and at the ingredients etc and realise its a ‘swindle’; and placebo gel ‘form of fraud’


Hahahaha! If it were that easy, LiarBOoth, I'm damn sure you would have done it by now!

[broomrigg] 31/7/2023 10:34

LOLLLLLLL

"waste of money" = LBO's favourite fraudulent review phrase

The uninvested bellends (and yes, they could well all be the same sad loser) posting all the time as they cry over the strong share price, solid at 55p and further roll-out news expected any day :-)

[petroc] 31/7/2023 10:23

Yet another happy customer on Amazon:

' Amazon Customer
5.0 out of 5 stars Good item
Reviewed in the United Kingdom on 28 July 2023
Verified Purchase
Just what I thought It was.'

___________________________________

I notice that jonnybutler has edited his poor review and corrected the spelling of '...waist of money'.

Strangely, that spelling mistake has been made consistently by the person or people behind these poor reviews.

[thebutler] 31/7/2023 10:07

Yet another unhappy customer on Amazon:

"This product does not work, total waste of money. The organisation seller this should be taken to book on this product."

They keep rolling in!

[broomrigg] 31/7/2023 09:25

"only 1 in 10,000 sales results in a complaint"

[j777j] 31/7/2023 08:53

New fireside chat Liberum and the Ceo







"taken 25% of the UK market
"getting repeat purchases" "20 approaches for China"
"going from 1 to 3 manufacturers

[petroc] 31/7/2023 08:19

LiarBOoth yet again taking over glavey's nocturnal emmissions! They're either the same person, or they both work as night watchmen at the same out of town warehouse!

Bear in mind of course that I work for FUM! Bwahahahaha!

[ajmace] 31/7/2023 07:25

If it works it doesn't matter whether it has an enforceable patent.Futura is the first company who have marketed a device that definitely assists with ED. Of course it doesn't work for all customers. The trial never said that it would.Meanwhile the packets of Eroxon continue to be sold in ever larger numbers.Futura has a enviable future and the share price will respond.

[thebutler] 30/7/2023 11:20

Claiming a placebo as being "clinically proven" is akin to selling sugar pills (which may have been used as a placebo in a pain relief trial) as a remedy for pain relief claiming it to be "clinically proven". Surely that's not right? As I say, this is a train crash waiting to happen.

And I notice the "number of people looking at this right now" for eroxon on the Boots website has fallen through the floor, and the sales on Amazon are going down. I suppose, with it being a placebo, if some clown claims it works, then has run out of tubes but then finds he can perform without eroxon having gotten over his mental block, then he didn't have ED after all and won't bother forking out another 25 quid for some junk.

Apparently Walmart pulled Lifestyles Epic (aka PET) as unit sales failed to reach the required quota, I would also imagine Boots and Amazon have target levels below which it's not commercially viable to continue selling. Will they cease selling? We shall see.

[beanol] 30/7/2023 01:47

The CEO Barder interview and the American guy on YouTube speaking about Eroxon are tremendous. Just don't see how it could be a con given the range and quantity of tests it has been subject to. Barder's replies and comments seem authentic and are convincing. Here however is the response I got from Haleon in response to a question from me as to why they had not even posted the deal with Futura on their website. Obviously need to bear in mind it's a £31bn company:"....As you would expect we have a process to review all news or developments on an ongoing basis to determine what is material for Haleon and what under current regulation and best market practice needs disclosure to the market in the appropriate form. In this instance for the Haleon group, amongst other considerations, this transaction was not deemed financially significant enough to merit a separate market release.We are currently in a closed period until 2 August when we release our H1 2023 results so there may be some analyst questions on this news then.

[stux] 29/7/2023 17:27

That’s a really good point Petroc, I wonder how many negative comments is the result of rubbing it into the whole member rather than reading the instructions??

[broomrigg] 29/7/2023 16:46

Cheers for posting that info petroc....that neg review looks right out of the (very limited) LBO phrase book.

What's much more significant is that, as per the recent James Barder interview, only 1 in 10,000 sales have resulted in a complaint. That's 1 complaint for every £250,000 of sales. Nada.




:-)

[petroc] 29/7/2023 13:15

*AMAZON UPDATE* (Because I know jonnybutler won't be sharing this)

1.0 out of 5 stars Totally useless.

The individual tubes are far too small so don't contain enough gel to apply & coat the designated body part unless you happen to be "very tiny" so this product in its current form is completely ineffective & is very expensive for no results, do not waste your well earned money. Will return it, very disappointed 😞

_______________

5.0 out of 5 stars Easy to use
Reviewed in the United Kingdom on 27 July 2023
Works very well.

__________________

So out of the two last reviews we have a 5 star with confirmation that Eroxon works, and a 1 star from someone who can't even read the instructions properly. Not surprised it didn't work for him, if he indeed has tried it!

Pmsl, as jonnybutler would say!